WallStSmart
BRKR

Bruker Corporation

NASDAQ: BRKR · HEALTHCARE · MEDICAL DEVICES

$36.71
+7.06% today

Updated 2026-04-30

Market cap
$5.52B
P/E ratio
P/S ratio
1.61x
EPS (TTM)
$-0.15
Dividend yield
0.55%
52W range
$28 – $56
Volume
2.0M

Bruker Corporation (BRKR) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
6 of 8
Last 8 quarters
Avg EPS surprise
+0.2%
Last 4 quarters
Revenue YoY growth
-0.2%
Most recent quarter
EPS YoY growth
-22.4%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-0.9%
Last 3 reports
Positive reaction rate
67%
2 of 3 quarters
Largest single-day move
-15.6%
2025-08-04
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-02-17$0.59-9.1%$36.51$39.76+8.9%
2025-11-04$0.45+40.6%$38.71$40.20+3.8%
2025-08-04$0.05-37.5%$37.99$32.07-15.6%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$0.65$0.59-9.1%$977.20M-0.2%
2025-09-30$0.32$0.45+40.6%$860.50M-0.5%
2025-06-30$0.08$0.05-37.5%$797.40M-0.4%
2025-03-31$0.44$0.47+6.8%$801.40M+11.0%
2024-12-31$0.74$0.76+2.7%$979.60M+14.6%
2024-09-30$0.60$0.60+0.0%$864.40M+16.4%
2024-06-30$0.52$0.52+0.0%$800.70M+17.4%
2024-03-31$0.46$0.53+15.2%$721.70M
2023-12-31$0.68$0.80+17.6%$854.50M
2023-09-30$0.63$0.74+17.5%$742.80M
2023-06-30$0.49$0.50+2.0%$681.90M

Frequently asked questions

Has Bruker Corporation beaten earnings estimates?
Bruker Corporation has beaten Wall Street EPS estimates in 6 of its last 8 quarterly reports, with an average EPS surprise of +0.2% over the last 4 quarters.
How does BRKR stock react to earnings?
BRKR stock has moved an average of -0.9% in the trading day following earnings over its last 3 reports, with positive reactions in 67% of those quarters.
What is Bruker Corporation's revenue growth rate?
Bruker Corporation reported year-over-year revenue growth of -0.2% in its most recent quarter, with EPS growing -22.4% year-over-year.